Moderate riskFDA DeviceClass II

Biomerieux VITEK 2 AST-N461 test kit recalled for card pouch damage causing false antibiotic resistance results

Some units of the Biomerieux VITEK 2 AST-N461 test kit used to determine antibiotic susceptibility in gram-negative bacteria have damaged card pouches. This damage can cause the test to report false resistant results, which may lead to use of less effective antibiotics or unnecessary antibiotic combinations.

From the FDA notice · Read the official notice ↗ · All bioMérieux recalls

What to do

  1. Check if your laboratory received units from lot 1333393504 (UDI-DI 03573026637712)
  2. Do not use affected units for patient testing
  3. Contact Biomerieux for replacement units or further instructions
  4. Review any patient results from this lot for accuracy

Is yours affected?

Compare your label or packaging with the recalled product.

Product
VITEK 2 AST-N461 TEST KIT, GRAM NEGATIVE SUSCEPTIBILITY TESTING - AUTOMATED, Reference Number 424811
Sold in
Nationwide
Made for
All ages (under 100 years)

Details

Units affected
97680 units
Illnesses reported
None reported
Manufactured in
595 Anglum Rd, Hazelwood, MO, United States
Classification
Class II
Recall number
Z-3231-2026

In the FDA's words

Description
VITEK 2 AST-N461 TEST KIT, GRAM NEGATIVE SUSCEPTIBILITY TESTING - AUTOMATED, Reference Number 424811 The issue is related to card pouch damage associated with a portion of the lot which was produced on a specific card pouching device, in a specific timeframe, causing a potential risk of false resistant results. False resistant results may lead to the use of less effective antibiotic treatments or the association of multiple antibiotics having negative side effects, which could potentially impact patient s health. UDI-DI 03573026637712; Lot Number 1333393504 Distribution: International distribution to the countries of Austria, Germany, Luxembourg. Affected quantity: 97680 units
Hazard
The issue is related to card pouch damage associated with a portion of the lot which was produced on a specific card pouching device, in a specific timeframe, causing a potential risk of false resistant results. False resistant results may lead to the use of less effective antibiotic treatments or the association of multiple antibiotics having negative side effects, which could potentially impact patient s health.

Related topics